Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
β Scribed by Michael C. Kew
- Book ID
- 111237198
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 105 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, we retrospectively analyzed 260 patients, 146 of whom were followed for a mean of 31.4 c 1.8 mo. Human immunodeficiency v
Hepatitis B virus (HBV) is an important etiologic agent of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Although the mechanism whereby HBV causes HCC is not fully understood, it is likely that there are many relevant molecular pathways that contribute to the development of HBV-a
## Isolated rat hepatocytes were used as an in vitro model to investigate a possible interaction between oxytetracycline (OXT) and aflatoxin B1 (AFB1). L D H leakage, R N A and protein synthesis and glycogen accumulation were measured in the presence of both drugs, either separately or in combinatio